Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cervical cancer screening.

Kevin Holcomb1, Carolyn D Runowicz

  • 1Division of Gynecologic Oncology, Beth Israel Medical Center, New York, NY 10003, USA.

Surgical Oncology Clinics of North America
|October 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Pleurothallis pembertonii</i> (Orchidaceae, Pleurothallidinae), a new species from northwestern Ecuador in the Tropical Andes Biodiversity Hotspot.

PhytoKeys·2026
Same author

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

Science advances·2026
Same author

Hypofractionated short course radiation therapy for recurrent ovarian cancer.

Gynecologic oncology reports·2026
Same author

Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort.

Communications medicine·2026
Same author

Can we talk about sex? Feasibility of universal sexual health screening for BRCA1/2 patients.

The journal of sexual medicine·2025
Same author

Recent Advances in Diagnostic Strategies and Nanotechnology-Based Therapies for Ovarian Cancer Treatment.

ACS applied bio materials·2025

Cervical cytology screening significantly reduces invasive cervical cancer. Advances in screening and HPV vaccines aim to further decrease mortality from this common female cancer.

Area of Science:

  • Gynecology
  • Oncology
  • Public Health

Background:

  • Cervical cytology, particularly the Pap smear, has been highly effective in reducing cervical cancer incidence and mortality.
  • The Bethesda System standardizes reporting for abnormal cervical cytology, incorporating understanding of HPV-related precancers.
  • Despite successes, challenges remain, including unscreened/underscreened populations and limitations of current screening methods.

Purpose of the Study:

  • To review the success of cervical cytology as a cancer screening tool.
  • To discuss advancements in cervical cancer screening and prevention.
  • To highlight the ongoing challenges and future directions in managing cervical cancer.

Main Methods:

  • Review of established cervical cytology screening programs and their impact.

Related Experiment Videos

  • Discussion of emerging technologies such as liquid-based cytology, HPV typing, and direct visualization.
  • Examination of the role of HPV vaccines in cervical cancer prevention.

    • Main Results:

    • Comprehensive cervical cancer screening programs have led to significant decreases in incidence and mortality.
    • New technologies aim to improve the accuracy and effectiveness of cervical cancer screening.
    • HPV vaccines are under development as a future preventive measure.

    Conclusions:

    • Cervical cytology remains a cornerstone of cervical cancer prevention, with ongoing improvements.
    • Addressing screening gaps and embracing new technologies are crucial for further reducing cervical cancer burden.
    • HPV vaccination holds promise for future primary prevention of cervical cancer.